Andere talen SUSMED,Inc.

Aandelen

4263

JP3319150003

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
600 ^JPY	0,00%		+3,09%	-55,06%

2022	Walgreens Boots Alliance, Inc. Sluit zich aan bij Partnerschap Duurzame Geneesmiddelen	CI
2022	Aculys Pharma en SUSMED sluiten een contract om de klinische studie uit te voeren met Blockchain technologie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index	18-09-23
DTx von SUSMED wurde in Japan für die Behandlung von Schlaflosigkeit zugelassen	25-08-23
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia	25-08-23
Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership	04-10-22
Aculys Pharma und SUSMED schließen Vertrag über Durchführung von weltweit erster klinischer Studie mit Blockchain-Technologie	14-07-22
Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology	13-07-22
Aculys Pharma and SUSMED Enter into A Contract to Conduct the Clinical Trial Utilizing Blockchain Technology	13-07-22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2022.	21-06-22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2022.	23-03-22
CollaboCreate Co., Ltd. announced that it has received funding from SUSMED,Inc.	10-03-22
Shionogi Signs up to $41 Million Commercialization Contract for Insomnia App	28-12-21
Shionogi & Co., Ltd. Announces Commercialization Agreement with SUSMED Co., Ltd. for Digital Therapeutic App for Insomnia	27-12-21
SUSMED,Inc. has completed an IPO in the amount of ¥3.65613 billion.	24-12-21
SUSMED,Inc. has filed an IPO.	19-11-21
SUSMED Co., Ltd. announced that it has received funding from Suzuken Co., Ltd.	30-10-20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	27-10-20
SUSMED Co., Ltd. announced that it has received ¥200 million in funding from Sumitomo Corporation	25-08-20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	11-05-20
SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited	04-06-18

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Behoud en verbeter je beleggingsprestaties met onze gratis inhoud

Mijn beleggingen veiligstellen

fermer